Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1996-7-9
|
| pubmed:abstractText |
Although epipodophyllotoxins are commonly used in contemporary treatment regimens for acute lymphoblastic leukemia (ALL), their potential role in CNS-directed therapy has received little attention. We prospectively studied 20 children during initial remission of ALL and 16 children at relapse to assess CSF penetration of etoposide.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0732-183X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
399-404
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8636749-Administration, Oral,
pubmed-meshheading:8636749-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:8636749-Child,
pubmed-meshheading:8636749-Etoposide,
pubmed-meshheading:8636749-Humans,
pubmed-meshheading:8636749-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:8636749-Prospective Studies,
pubmed-meshheading:8636749-Remission Induction
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia.
|
| pubmed:affiliation |
Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|